• Explore /
  • Poster
  • / Updated analysis: Observational cohort study of first-line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802)—Sub-group analysis by <i>KRAS </i>Exon2 status.

Updated analysis: Observational cohort study of first-line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802)—Sub-group analysis by KRAS Exon2 status.

Abstract Poster

Authors

Michio Nakamura

Michio Nakamura

Department of Gastroenterology, Sapporo City General Hospital, Sapporo, Japan

Michio Nakamura , Satoshi Yuki , Kentaro Sawada , Ayane Oba , Atsushi Sato , Takashi Kato , Takashi Meguro , Nobuyuki Ehira , Miki Tateyama , Kazuteru Hatanaka , Kazunori Eto , Hiroyuki Okuda , Yoshimitsu Kobayashi , Osamu Muto , Masakazu Abe , Kanji Kato , Mineo Kudo , Kencho Miyashita , Yuh Sakata , Yoshito Komatsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Prevention, Diagnosis, and Screening

Clinical Trial Registration Number

UMIN000018935

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 522)

DOI

10.1200/jco.2016.34.4_suppl.522

Abstract #

522

Poster Bd #

B13

Abstract Disclosures

Similar Posters

First Author: Takenori Takahata

First Author: Tetsuya Eto

First Author: Kazuteru Hatanaka

First Author: Dominik Paul Modest